Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Of The Effect Of Mistletoe Extract, A Complementary Medicine Botanical, On Pharmacokinetics, Pharmacodynamics And Safety Of Gemcitabine In Patients With Advanced Solid Tumors

NCT00049608 is registered in ClinicalTrials.gov with National Center for Complementary and Integrative Health (NCCIH) as lead sponsor.

NCT NCT00049608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00049608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Of The Effect Of Mistletoe Extract, A Complementary Medicine Botanical, On Pharmacokinetics, Pharmacodynamics And Safety Of Gemcitabine In Patients With Advanced Solid Tumors
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2002
Completion date
August 31, 2011
Enrollment
51 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, lung cancer, pancreatic cancer